Literature DB >> 19786665

Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factor.

Francisco A Perez1, Corinne L Fligner, Evan Y Yu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19786665     DOI： 10.1200/JCO.2009.22.4931

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

Review 1.  Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors.

Authors:  Nandini Dey; Pradip De; Leyland-Jones Brian
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

2.  Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes.

Authors:  Marcin Kowanetz; Xiumin Wu; John Lee; Martha Tan; Thijs Hagenbeek; Xueping Qu; Lanlan Yu; Jed Ross; Nina Korsisaari; Tim Cao; Hani Bou-Reslan; Dara Kallop; Robby Weimer; Mary J C Ludlam; Joshua S Kaminker; Zora Modrusan; Nicholas van Bruggen; Franklin V Peale; Richard Carano; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-16       Impact factor: 11.205

Review 3.  GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.

Authors:  Anil Kumar; Adeleh Taghi Khani; Ashly Sanchez Ortiz; Srividya Swaminathan
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

4.  Serum G-CSF May Be a More Valuable Biomarker than Image Evaluation in G-CSF-Producing Urothelial Carcinoma: A Case Report.

Authors:  Kento Morozumi; Shunichi Namiki; Takashi Kudo; Masataka Aizawa; Naomasa Ioritani
Journal:  Case Rep Oncol       Date:  2017-04-24

5.  Paraneoplastic Leukemoid Reaction after Primary Tumor Resection in Patients with Urothelial Carcinoma: A Report of 2 Cases.

Authors:  Shien-Tung Pan; Shu-Ping Tseng; Chiou-Huey Wang; Yu-Ting Chou
Journal:  Clin Pathol       Date:  2021-07-12

Review 6.  A role for G-CSF and GM-CSF in nonmyeloid cancers.

Authors:  Alexander M Aliper; Victoria P Frieden-Korovkina; Anton Buzdin; Sergey A Roumiantsev; Alex Zhavoronkov
Journal:  Cancer Med       Date:  2014-04-02       Impact factor: 4.452

7.  Leukemoid reaction in sarcomatoid renal cell carcinoma: a two-case report.

Authors:  Weiping Huang; Feng Wang; Yeping Li; Feifei Duan; Zhixian Yu
Journal:  World J Surg Oncol       Date:  2014-04-19       Impact factor: 2.754

Review 8.  Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor--a potential neoplastic marker: a case report and review of the literature.

Authors:  Anup Kasi Loknath Kumar; Megha Teeka Satyan; Jeffrey Holzbeierlein; Moben Mirza; Peter Van Veldhuizen
Journal:  J Med Case Rep       Date:  2014-05-13

9.  CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.

Authors:  Yi-Ying Lee; Wen-Jeng Wu; Chun-Nung Huang; Ching-Chia Li; Wei-Ming Li; Bi-Wen Yeh; Peir-In Liang; Ting-Feng Wu; Chien-Feng Li
Journal:  J Cancer       Date:  2016-03-26       Impact factor: 4.207

Review 10.  Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types.

Authors:  In-Sun Hong
Journal:  Exp Mol Med       Date:  2016-07-01       Impact factor: 8.718
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.